Phi Life Sciences is a Molecular Diagnostic and Laboratory Service company that aims to help patients by reducing disease mortality and adverse drug reactions through affordable, state of the art screening and diagnostic technologies. Phi Life Sciences is the bridge between scientists with innovative technologies and the patients and doctors whom they can benefit. We build this bridge through products developed in laboratory services and offered to patients and doctors through clinical services. Phi Life sciences aims to improve the efficiency, delivery, accessibility, and utility of molecular testing services through innovative technologies, licensed products, and clinically actionable result that empower physicians to deliver precision treatments and diagnoses by incorporating molecular tests that will improve their patients’ health. Phi Life Sciences aims to improve patient health through the use of cutting edge molecular diagnostic tools. We exist to achieve the human potential.